The stage and severity of COVID-19 are important factors associated with the expression of secretory IgA, but variations in the immune system and genetic differences among patients may have led to differences in the humoral response to SARS-CoV-2 detected by different research groups. This evidence concerns the gene CD79A and COVID-19.